Lipid metabolism reprogramming in renal cell carcinomas

Med Oncol. 2024 Sep 6;41(10):243. doi: 10.1007/s12032-024-02484-5.

Abstract

This study investigates the intricate mechanisms underlying the correlation between elevated consumption of harmful fats and the onset of kidney malignancies. The rise in global obesity rates has been accompanied by an increased prevalence of renal cancers, prompting an exploration into the molecular pathways and biological processes linking these phenomena. Through an extensive review of current literature and clinical studies, we identify potential key factors contributing to the carcinogenic influence of harmful fats on renal tissues. Our analysis highlights the role of adipose tissue-derived factors, inflammatory mediators, and lipid metabolism dysregulation in fostering a microenvironment conducive to renal tumorigenesis. Furthermore, we delve into the impact of harmful fats on signaling pathways associated with cell proliferation, apoptosis evasion, and angiogenesis within the renal parenchyma. This review underscores the importance of elucidating the molecular intricacies linking lipid metabolism and kidney malignancies, offering a foundation for future research and the development of targeted preventive and therapeutic interventions. The findings discussed herein contribute to our understanding of the complex relationship between lipid mediators and renal cancer, providing a basis for public health strategies aimed at mitigating the impact of harmful fats on kidney health.

Keywords: Kidney malignancies; Lipid metabolism; Obesity.

Publication types

  • Review

MeSH terms

  • Animals
  • Carcinoma, Renal Cell* / metabolism
  • Carcinoma, Renal Cell* / pathology
  • Humans
  • Kidney Neoplasms* / metabolism
  • Kidney Neoplasms* / pathology
  • Lipid Metabolism* / physiology
  • Metabolic Reprogramming
  • Signal Transduction / physiology